• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Uwagawa Tadashi  宇和川 匡

ORCIDConnect your ORCID iD *help
… Alternative Names

宇和川 匡  ウワガワ タダシ

Less
Researcher Number 70287209
Other IDs
Affiliation (Current) 2025: 東京慈恵会医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help 2025: 東京慈恵会医科大学, 医学部, 教授
2021 – 2023: 東京慈恵会医科大学, 医学部, 准教授
1998 – 1999: 東京慈恵会医科大学, 医学部, 助手
Review Section/Research Field
Principal Investigator
Basic Section 55020:Digestive surgery-related / Digestive surgery
Keywords
Principal Investigator
オートファジー / ライソゾーム / アポトーシス / 酸性β-グルコシダーゼ / ライソゾーム酵素 / 膵臓癌 / 酸性セラミダーゼ / APC遺伝子 / 大腸癌モデルマウス / 肝細胞成長促成因子 … More / loxP system / Cre / 遺伝子治療 / 切除後肝再生 Less
  • Research Projects

    (3 results)
  • Research Products

    (10 results)
  • Co-Researchers

    (8 People)
  •  膵癌のエピゲノム解析による化学療法耐性獲得メカニズムの解明と革新的治療法の開発Principal Investigator

    • Principal Investigator
      宇和川 匡
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 55020:Digestive surgery-related
    • Research Institution
      Jikei University School of Medicine
  •  Development of innovative treatments based on pancreatic cancer-specific energy metabolism mechanisms.Principal Investigator

    • Principal Investigator
      Uwagawa Tadashi
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 55020:Digestive surgery-related
    • Research Institution
      Jikei University School of Medicine
  •  肝切除後の肝再生補助に関する遺伝子治療の新案-Cre/loxP systemを用いた導入遺伝子発現のコントロールは可能か?Principal Investigator

    • Principal Investigator
      宇和川 匡
    • Project Period (FY)
      1998 – 1999
    • Research Category
      Grant-in-Aid for Encouragement of Young Scientists (A)
    • Research Field
      Digestive surgery
    • Research Institution
      Jikei University School of Medicine

All 2024 2023 2022 2021

All Journal Article

  • [Journal Article] The prognosis-based classification model in resectable pancreatic cancer2024

    • Author(s)
      Okui Norimitsu、Tsunematsu Masashi、Furukawa Kenei、Shirai Yoshihiiro、Haruki Koichiro、Sakamoto Taro、Uwagawa Tadashi、Onda Shinji、Gocho Takeshi、Ikegami Toru
    • Journal Title

      Surgical Oncology

      Volume: 52 Pages: 102035-102035

    • DOI

      10.1016/j.suronc.2024.102035

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22K16501, KAKENHI-PROJECT-21K08806
  • [Journal Article] Osteosarcopenia is a significant predictor of recurrence and the prognosis after resection for extrahepatic bile duct cancer2023

    • Author(s)
      Matsumoto Michinori、Onda Shinji、Igarashi Yosuke、Hamura Ryoga、Uwagawa Tadashi、Furukawa Kenei、Shirai Yoshihiro、Gocho Takeshi、Haruki Koichiro、Ikegami Toru
    • Journal Title

      Surgery Today

      Volume: 54 Issue: 5 Pages: 407-418

    • DOI

      10.1007/s00595-023-02747-0

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K08806
  • [Journal Article] Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12?months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trial2023

    • Author(s)
      Kayashima Hiroto、Itoh Shinji、Shimokawa Mototsugu、Hayashi Hiromitsu、Takamori Hiroshi、Fukuzawa Kengo、Ninomiya Mizuki、Araki Kenichiro、Yamashita Yo-ichi、Sugimachi Keishi、Uchiyama Hideaki、Morine Yuji、Utsunomiya Tohru、Uwagawa Tadashi、Maeda Takashi、Baba Hideo、Yoshizumi Tomoharu
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 28 Issue: 11 Pages: 1520-1529

    • DOI

      10.1007/s10147-023-02399-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K08806
  • [Journal Article] Oesophageal elongation using magnets in adult patients.2022

    • Author(s)
      Kamada T, Ohdaira H, Okada S, Takahashi J, Nakashima K, Nakaseko Y, Suzuki N, Uwagawa T, Yoshida M, Yamanouchi E, Suzuki Y.
    • Journal Title

      Br J Surg

      Volume: 109 Pages: 472-473

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K08806
  • [Journal Article] Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.2022

    • Author(s)
      Uwagawa T, Sakamoto T, Gocho T, Shiba H, Onda S, Yasuda J, Shirai Y, Hamura R, Furukawa K, Yanaga K, Ikegami T.
    • Journal Title

      PLoS One

      Volume: 17

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K08806
  • [Journal Article] The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis.2022

    • Author(s)
      Hamura R, Haruki K, Taniai T, Yanagaki M, Shirai Y, Furukawa K, Usuba T, Fujioka S, Okamoto T, Nakabayashi Y, Uwagawa T, Ikegami T.
    • Journal Title

      Int J Clin Oncol

      Volume: 27 Pages: 1188-1195

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K08806
  • [Journal Article] Inhibition of lysosomal acid β-glucosidase induces cell apoptosis via impairing mitochondrial clearance in pancreatic cancer.2022

    • Author(s)
      Yanagaki M, Shirai Y, Shimada Y, Hamura R, Taniai T, Horiuchi T, Takada N, Haruki K, Furukawa K, Uwagawa T, Kobayashi H, Ikegami T.
    • Journal Title

      Carcinogenesis

      Volume: 43 Pages: 826-837

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K08806
  • [Journal Article] Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)2021

    • Author(s)
      Maruki Y, Morizane C, Arai Y, Ikeda M, Ueno M, Ioka T, Naganuma A, Furukawa M, Mizuno N, Uwagawa T, Takahara N, Kanai M, Asagi A, Shimizu S, Miyamoto A, Yukisawa S, Kadokura M, Kojima Y, Furuse J, Nakajima TE, Sudo K, Kobayashi N, Hama N, Yamanaka T, Shibata T, Okusaka T.
    • Journal Title

      J Gastroenterol

      Volume: 56 Pages: 250-260

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K08806
  • [Journal Article] Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells2021

    • Author(s)
      Taniai T, Shirai Y, Shimada Y, Hamura R, Yanagaki M, Takada N, Horiuchi T, Haruki K, Furukawa K, Uwagawa T, Tsuboi K, Okamoto Y, Shimada S, Tanaka S, Ohashi T, Ikegami T.
    • Journal Title

      Cancer Sci

      Volume: 112 Pages: 4570-4579

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K08806
  • [Journal Article] Phase II Study of Adjuvant Chemotherapy With Gemcitabine and Nafamostat Mesilate for Pancreatic Cancer2021

    • Author(s)
      Uwagawa T, Sakamoto T, Yasuda J, Shiozaki H, Furukawa K, Onda S, Gocho T, Shiba H, Yanaga K.
    • Journal Title

      Pancreas

      Volume: 50 Pages: 313-316

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K08806
  • 1.  恩田 真二 (10459620)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 2.  白井 祥睦 (10785364)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 5 results
  • 3.  阿部 恭平 (30751292)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  後町 武志 (40338893)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 5.  春木 孝一郎 (60720894)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 4 results
  • 6.  池上 徹 (80432938)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 5 results
  • 7.  古川 賢英 (80624973)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 7 results
  • 8.  SAKAMOTO Taro
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi